We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$11.2B
AUM Growth
+$940M
Cap. Flow
+$1.12B
Cap. Flow %
10.03%
Top 10 Hldgs %
10.74%
Holding
2,900
New
574
Increased
959
Reduced
752
Closed
610

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$93.4M
2
AAPL icon
Apple
AAPL
+$80.7M
3
DRI icon
Darden Restaurants
DRI
+$70M
4
CVS icon
CVS Health
CVS
+$63.6M
5
V icon
Visa
V
+$54.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.85%
2 Technology 11.68%
3 Financials 10.7%
4 Healthcare 9.66%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMY icon
2226
Harmony Gold Mining
HMY
$9.92B
$62K ﹤0.01%
+21,868
New +$64.1K
III icon
2227
Information Services Group
III
$185M
$62K ﹤0.01%
24,957
+308
+1% +$827
SPWH icon
2228
Sportsman's Warehouse
SPWH
$43.7M
$59K ﹤0.01%
11,355
-51,910
-82% -$223K
TUSK icon
2229
Mammoth Energy Services
TUSK
$132M
$59K ﹤0.01%
+23,800
New +$113K
AXLA
2230
DELISTED
Axcella Health Inc. Common Stock
AXLA
$58K ﹤0.01%
411
-233
-36% -$43.2K
SUP
2231
DELISTED
Superior Industries International
SUP
$57K ﹤0.01%
19,722
-51,701
-72% -$151K
AGRX
2232
DELISTED
Agile Therapeutics
AGRX
$57K ﹤0.01%
+24
New +$59.1K
LNAI
2233
Lunai Bioworks
LNAI
$10.6M
$56K ﹤0.01%
127
-74
-37% -$28.3K
EGIO
2234
DELISTED
Edgio, Inc. Common Stock
EGIO
$56K ﹤0.01%
+464
New +$49K
DRRX
2235
DELISTED
DURECT Corp
DRRX
$55K ﹤0.01%
+2,970
New +$40.1K
TANH icon
2236
Tantech Holdings
TANH
$6.07M
$53K ﹤0.01%
4
-1
-20% -$14.3K
VRN
2237
DELISTED
Veren
VRN
$52K ﹤0.01%
+12,207
New +$42.3K
AUO
2238
DELISTED
AU Optronics Corp
AUO
$52K ﹤0.01%
+21,006
New +$55K
GALT icon
2239
Galectin Therapeutics
GALT
$229M
$51K ﹤0.01%
13,901
+3,788
+37% +$13.7K
TEN
2240
Tsakos Energy Navigation Ltd
TEN
$1.19B
$50K ﹤0.01%
+3,396
New +$52.1K
ONIT
2241
Onity Group
ONIT
$333M
$50K ﹤0.01%
1,762
-446
-20% -$12.5K
ELOX
2242
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$50K ﹤0.01%
+279
New +$79.4K
CKPT
2243
DELISTED
Checkpoint Therapeutics
CKPT
$49K ﹤0.01%
+1,971
New +$54.1K
SID icon
2244
Companhia Siderúrgica Nacional
SID
$1.43B
$49K ﹤0.01%
+15,624
New +$59.4K
GSV
2245
DELISTED
Gold Standard Ventures Corp.
GSV
$49K ﹤0.01%
64,189
-115,402
-64% -$112K
HBIO icon
2246
Harvard Bioscience
HBIO
$27.1M
$48K ﹤0.01%
1,574
-10,132
-87% -$252K
INTT icon
2247
inTEST
INTT
$173M
$47K ﹤0.01%
10,021
-11,279
-53% -$50.6K
TLGT
2248
DELISTED
Teligent, Inc
TLGT
$47K ﹤0.01%
4,911
+3,499
+248% +$27.6K
ALBT
2249
DELISTED
Avalon GloboCare
ALBT
$46K ﹤0.01%
+164
New +$51.7K
HL icon
2250
Hecla Mining
HL
$10.2B
$46K ﹤0.01%
+26,115
New +$47.1K

Similar funds

Squarepoint's Q3 2019 Portfolio in Review

As of Q3 2019, Squarepoint held 2,900 positions worth $11.2B, up 9.2% from $10.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Squarepoint deployed $1.12B of net new capital in Q3 2019, opening 574 new positions and adding to 959 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $93.4M trimmed.

  • Squarepoint's largest Q3 2019 buy was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.
  • Squarepoint added most to Costco in Q3 2019, an estimated $137M increase.
  • Squarepoint's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $93.4M.
  • Squarepoint fully exited Visa in Q3 2019, selling an estimated $54.9M.
  • Squarepoint's ten largest holdings make up 11% of its $11.2B portfolio in Q3 2019.
  • Squarepoint opened 574 new positions and closed 610 in Q3 2019.
  • Squarepoint's portfolio value rose 9.2% quarter-over-quarter to $11.2B.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.